Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Evofem Biosciences Inc (EVFM)
Evofem Biosciences Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evofem Biosciences Inc 7770 Regents Road Suite 113-618 SAN DIEGO CA 92122 USA

www.evofem.com P: 858-550-1900

Description:

Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA.

Key Statistics

Overview:

Market Capitalization, $K 510
Enterprise Value, $K -3,470
Shares Outstanding, K 30,363
Annual Sales, $ 16,840 K
Annual Net Income, $ -76,700 K
Last Quarter Sales, $ 5,110 K
Last Quarter Net Income, $ 66,010 K
EBIT, $ -26,520 K
EBITDA, $ -25,500 K
60-Month Beta -1.09
% of Insider Shareholders 0.21%
% of Institutional Shareholders 0.00%
Float, K 30,299
% Float 99.79%
Short Volume Ratio 0.35

Growth:

1-Year Return -99.45%
3-Year Return -100.00%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.10 on 11/14/23
Latest Earnings Date 01/05/24
Earnings Per Share ttm -7.18
EPS Growth vs. Prev Qtr 101.84%
EPS Growth vs. Prev Year 102.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-125 on 05/18/23

EVFM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -77.85%
Return-on-Assets % 237.94%
Profit Margin % -455.46%
Debt/Equity 0.00
Price/Sales 0.43
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -5.76
Interest Coverage -0.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar